MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RVP made $10,085,723 in revenue. $313,436 in net income. Net profit margin of 3.11%.

Income Overview

Revenue
$10,085,723
Net Income
$313,436
Net Profit Margin
3.11%
EPS
$0.01
Unit: Dollar
Revenue Breakdown
    • United States Sales
    • North And South America Sales Ex...
    • Other International Sales
Revenue Breakdown
    • Syringes
    • Easy Point Needles
    • Blood Collection Products
    • Other Products
Revenue Breakdown
    • United States Sales
    • North And South America Sales Ex...
    • Other International Sales

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Sales, net
10,085,723 10,445,733 8,295,173 8,485,201.5*
Product
7,572,544 9,721,614 --
Royalty
827,275 831,209 --
Total cost of sales
8,399,819 10,552,823 8,297,084 8,861,276.5*
Gross profit (loss)
1,685,904 -107,090 -1,911 -376,075*
Sales and marketing
1,583,760 1,661,743 1,601,808 1,012,579.5*
Research and development
199,462 160,049 191,192 113,262*
General and administrative
3,556,724 3,201,955 2,881,841 3,255,825.5*
Total operating expenses
5,339,946 5,023,747 4,674,841 4,381,667*
Loss from operations
-3,654,042 -5,130,837 -4,676,752 -4,757,742*
Litigation proceeds
-1,900,000 --
Other income - tia
1,516,268 1,471,235 1,482,819 1,483,840.5*
Unrealized gain (loss) on debt and equity securities
2,383,779 1,555,676 -7,156,513 11,301,303.5*
Loss on trading debt securities
-343 ---
Interest and other income
147,663 140,526 158,946 193,326*
Interest expense
20,585 22,257 23,455 29,041*
Net income (gain) before income taxes
372,740 -85,657 -10,214,955 8,191,687*
Provision (benefit) for income taxes
1,693 1,814 285,761 -4,051,732.5*
Net income (gain)
371,047 -87,471 -10,500,716 12,243,419.5*
Preferred stock dividend requirements
57,611 57,611 57,611 57,611*
Net income (gain) applicable to common shareholders
313,436 -145,082 -10,558,327 12,185,808.5
Basic EPS
0.01 0 -0.35 0.407
Diluted EPS
0.01 0 -0.35 0.407
Basic Average Shares
29,937,159 29,937,159 29,937,159 29,937,159
Diluted Average Shares
29,937,159 29,937,159 29,937,159 29,937,159
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Syringes$5,508,018 Easy Point Needles$3,303,166 Blood CollectionProducts$367,681 Other Products$8,711 Easy Point Needles$405,472 Syringes$144,326 Syringes$195,414 Easy Point Needles$145,116 Blood CollectionProducts$5,070 Other Products$2,749 United States Sales$9,187,576 North And SouthAmerica Sales Excluding...$549,798 Other InternationalSales$348,349 Unrealized gain (loss) ondebt and equity...$2,383,779 (64.42%↑ Y/Y)Other income - tia$1,516,268 (3.17%↑ Y/Y)Interest and other income$147,663 (-49.70%↓ Y/Y)Sales, net$10,085,723 (-2.52%↓ Y/Y)Net income (gain)before income taxes$372,740 (119.08%↑ Y/Y)Loss from operations-$3,654,042 (28.85%↑ Y/Y)Gross profit (loss)$1,685,904 (11483.55%↑ Y/Y)Interest expense$20,585 (-32.48%↓ Y/Y)Loss on trading debtsecurities-$343 Total cost of sales$8,399,819 (-18.93%↓ Y/Y)Net income (gain)$371,047 (119.31%↑ Y/Y)Provision (benefit) forincome taxes$1,693 (105.43%↑ Y/Y)Total operatingexpenses$5,339,946 (4.28%↑ Y/Y)Product$7,572,544 Royalty$827,275 Net income (gain)applicable to common...$313,436 (115.83%↑ Y/Y)Preferred stock dividendrequirements$57,611 (0.00%↑ Y/Y)General andadministrative$3,556,724 (11.25%↑ Y/Y)Sales and marketing$1,583,760 (-9.45%↓ Y/Y)Research and development$199,462 (14.18%↑ Y/Y)

RETRACTABLE TECHNOLOGIES INC (RVP)

RETRACTABLE TECHNOLOGIES INC (RVP)